Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Milwaukee Area Technical College unveiled a 2,000 square foot biotech classroom and lab at its downtown campus to train students starting in spring 2026.

Alexandria Real Estate Equities (ARE) had a lot to celebrate as it marked its 30th anniversary in business earlier this year, including nearly 27 years as a publicly-traded real estate investment ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Southwest Research Institute has upgraded its nuclear magnetic resonance (NMR) laboratory to offer robust chemical analysis ...

NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that is building a platform for interpreting ...

Vancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations ...

Dallas County is getting in on the Metroplex’s growing biotech boom. The county is building a 65,000-square-foot bio lab less than a mile from three of the city’s largest hospital systems. The ...

BOSTON — Real estate firms are hitting the breaks on laboratory development in Allston. A nearly billion-dollar project from National Development to redevelop a TV studio at 1170 Soldiers Field Rd. to ...

China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...